Amy VandenBerg

Keine laufenden Positionen mehr

50 Jahre

Health Technology

Consumer Services

Profil

Amy VandenBerg worked as a Vice President of Regulatory and Clinical Affairs at Obalon Therapeutics, Inc. from 2014 to 2019.
Prior to that, she worked as a Director of Regulatory Affairs at DexCom, Inc. from 2006 to 2008 and as a Manager of Clinical Trials at Cygnus, Inc. Additionally, she earned an undergraduate degree from St. Mary's College of California in 1998.

Ehemalige bekannte Positionen von Amy VandenBerg

Unternehmen	Position	Ende
DEXCOM, INC.	General Counsel	01.12.2008
Cygnus, Inc. Cygnus, Inc. Medical SpecialtiesHealth Technology Develops and manufactures glucose-monitoring devices	Corporate Officer/Principal	-
VYOME HOLDINGS, INC.	Technik-/Wissenschafts-/F&E-Leiter	-

Sehen Sie sich die Erfahrung von Amy VandenBerg im Detail an

Ausbildung von Amy VandenBerg

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Amy VandenBerg im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Private Unternehmen	4
Cygnus, Inc. Cygnus, Inc. Medical SpecialtiesHealth Technology Develops and manufactures glucose-monitoring devices	Health Technology
Obalon Therapeutics, Inc. Obalon Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops medical balloon technology for weight loss therapy	Health Technology
DexCom, Inc. DexCom, Inc. Medical SpecialtiesHealth Technology Designs, develops and commercializes continuous glucose monitoring systems for management of diabetes & metabolic health by patients, caregivers and clinicians	Health Technology
St. Mary's College of California St. Mary's College of California Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services